Charles Schwab Investment Management Inc Revolution Medicines, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,109,684 shares of RVMD stock, worth $48.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,109,684
Previous 1,052,263
5.46%
Holding current value
$48.9 Million
Previous $33.9 Million
26.99%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding RVMD
# of Institutions
231Shares Held
161MCall Options Held
251KPut Options Held
133K-
Vanguard Group Inc Valley Forge, PA14.4MShares$634 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA13.7MShares$602 Million0.1% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$591 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.76MShares$430 Million1.83% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$333 Million3.9% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.86B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...